LYRA THERAPEUTICS

lyra-therapeutics-logo

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. The company’s proprietary technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. The company’s initial product candidates, LYR-210 and LYR-... 220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of CRS. The therapeutic embedded within LYR-210 and LYR-220 is mometasone furoate, which is the active ingredient in various FDA-approved drugs and has a well-established efficacy and safety profile.

#SimilarOrganizations #People #Financial #Event #Website #More

LYRA THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics Wellness

Founded:
2005-01-01

Address:
Watertown, Massachusetts, United States

Country:
United States

Website Url:
http://www.lyratherapeutics.com

Total Employee:
11+

Status:
Active

Contact:
617.393.4600

Email Addresses:
[email protected]

Total Funding:
214.09 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

amicus-therapeutics-logo

Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

dystrogen-therapeutics-logo

Dystrogen Therapeutics

Dystrogen Therapeutics is a clinical-stage regenerative medicine company focusing on rare diseases.

eliem-therapeutics-logo

Eliem Therapeutics

Eliem Therapeutics is a clinical-stage biotechnology company developing treatments for nervous system disorders.

keeps-logo

Keeps

Keeps is a startup aimed at preventing and slowing age-related hair loss.

koya-medical-logo

Koya Medical

Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.

lifeguides-pbc-logo

LifeGuides, PBC

Modernizing human support & learning - The Marketplace for Life Experience. More casual than therapy, more qualified than a friend. B2B SaaS

lyndra-therapeutics-logo

Lyndra Therapeutics

Lyndra Therapeutics is a novel technology platform reinventing medicine for a healthier world.

mbx-biosciences-logo

MBX Biosciences

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

medable-logo

Medable

Medable is transforming clinical research and predictive medicine by creating a platform powered by patient generated data.

northsea-therapeutics-logo

NorthSea Therapeutics

NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.

nutcracker-therapeutics-logo

Nutcracker Therapeutics

Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.

oneskin-logo

OneSkin

OneSkin is a longevity company developing products designed to extend skin and body health by targeting aging at its source.

pinpoint-therapeutics-logo

Pinpoint Therapeutics

Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.

primaeva-medical-logo

Primaeva Medical

Primaeva Medical is a venture capital funded company developing devices for dermatologists, plastic surgeons and other cosmetic physicians.

pure-scientific-technologies-logo

Pure Scientific Technologies

Pure Scientific Technologies is a medical device startup company that develops a new patent-pending drug delivery system.

thermaband-logo

Thermaband

Thermaband is a health and wellness company empowering menopausal women with personal comfort on demand through a cooling/warming wearable.

treadwell-therapeutics-logo

Treadwell Therapeutics

Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.

x4-pharmaceuticals-logo

X4 Pharmaceuticals

X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.


Current Advisors List

harlan-w-waksal_image

Harlan W. Waksal Board of Director @ Lyra Therapeutics
Board_member

Current Employees Featured

george-whitesides_image

George Whitesides
George Whitesides Co-Founder @ Lyra Therapeutics
Co-Founder

robert-langer_image

Robert Langer
Robert Langer Co-founder @ Lyra Therapeutics
Co-founder

maria-palasis_image

Maria Palasis
Maria Palasis President, CEO @ Lyra Therapeutics
President, CEO
2018-01-01

corinne-noyes_image

Corinne Noyes
Corinne Noyes Senior Vice President of Commercial Strategy & Market Development @ Lyra Therapeutics
Senior Vice President of Commercial Strategy & Market Development

harlan-w-waksal_image

Harlan W. Waksal
Harlan W. Waksal Executive Chairman @ Lyra Therapeutics
Executive Chairman
2022-02-01

richard-nieman_image

Richard Nieman
Richard Nieman Chief Medical Officer @ Lyra Therapeutics
Chief Medical Officer
2022-07-01

pamela-nelson_image

Pamela Nelson
Pamela Nelson Senior Vice President, Regulatory Affairs @ Lyra Therapeutics
Senior Vice President, Regulatory Affairs
2020-08-01

vineeta-belanger_image

Vineeta Belanger
Vineeta Belanger Senior Vice President, Clinical Affairs @ Lyra Therapeutics
Senior Vice President, Clinical Affairs
2019-09-01

not_available_image

Jason Cavalier
Jason Cavalier Chief Financial Officer @ Lyra Therapeutics
Chief Financial Officer
2021-01-01

r-don-elsey_image

R Don Elsey
R Don Elsey Chief Financial Officer @ Lyra Therapeutics
Chief Financial Officer
2019-08-01

Founder


george-whitesides_image

George Whitesides

robert-langer_image

Robert Langer

Stock Details


Company's stock symbol is NASDAQ:LYRA

Investors List

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Post-IPO Equity - Lyra Therapeutics

samsara-biocapital_image

Samsara BioCapital

Samsara BioCapital investment in Post-IPO Equity - Lyra Therapeutics

north-bridge-venture-partners_image

North Bridge Venture Partners & Growth Equity

North Bridge Venture Partners & Growth Equity investment in Post-IPO Equity - Lyra Therapeutics

nantahala-capital-management_image

Nantahala Capital Management

Nantahala Capital Management investment in Post-IPO Equity - Lyra Therapeutics

pura-vida-investments_image

Pura Vida Investments

Pura Vida Investments investment in Post-IPO Equity - Lyra Therapeutics

venrock-healthcare-partners_image

Venrock Healthcare Capital Partners

Venrock Healthcare Capital Partners investment in Post-IPO Equity - Lyra Therapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series C - Lyra Therapeutics

soleus-capital_image

Soleus Capital

Soleus Capital investment in Series C - Lyra Therapeutics

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Series C - Lyra Therapeutics

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series C - Lyra Therapeutics

Official Site Inspections

http://www.lyratherapeutics.com Semrush global rank: 4.67 M Semrush visits lastest month: 2.09 K

  • Host name: 169.101.198.104.bc.googleusercontent.com
  • IP address: 104.198.101.169
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Lyra Therapeutics"

Lyra Therapeutics - Lyra Therapeutics

Lyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS).See details»

Company - Lyra Therapeutics

Lyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal sinuses which leads to debilitating …See details»

Leadership - Lyra Therapeutics

Harlan W. Waksal, M.D., has led several late-stage and commercial biotech and pharmaceutical companies as well as secured successful financial deals after scaling companies during more …See details»

Lyra Therapeutics - Crunchbase Company Profile

Lyra Therapeutics is a clinical-stage company developing medicines to treat ear, nose, and throat diseases. Private equity firms holding 39% of Lyra …See details»

Investor Relations - Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc. is a clinical-stage biotechnology company developing long-acting, anti-inflammatory nasal inserts for the treatment of chronic rhinosinusitis (CRS).See details»

Lyra Therapeutics - LinkedIn

Lyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal...See details»

Lyra Therapeutics - MassBio

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, local delivery of medications to diseased tissues not …See details»

Lyra Therapeutics, Inc. (LYRA) - Yahoo Finance Canada

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment...See details»

Lyra Therapeutics - Craft

Aug 13, 2024 · Lyra Therapeutics (formerly known as 480 Biomedical) is a therapeutics company focused on the development of integrated drug and delivery solutions for the localized …See details»

News Release - investors.lyratherapeutics.com

Jul 12, 2021 · A live webcast of the fireside chat presentation will be available in the Investor Relations section of the Company’s website at https://investors.lyratherapeutics.com. The …See details»

For Patients - Lyra Therapeutics

Patients try multiple approaches to seek CRS symptom relief, including over-the-counter remedies, sinus rinses, and prescribed steroids delivered via nasal spray or oral pills. These approaches are not effective in relieving CRS symptoms …See details»

Lyra Therapeutics Reports First Quarter 2024 Financial Results and ...

Lyra Therapeutics, Inc. is a clinical-stage biotechnology company developing therapies for the localized treatment of patients with chronic rhinosinusitis (CRS), a highly prevalent …See details»

Lyra Therapeutics Announces Positive Topline Results from …

WATERTOWN, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing …See details»

Technology - Lyra Therapeutics

Lyra Therapeutics’ proprietary technology is designed to enable sustained delivery of medication for up to six months of therapy per placement, targeting tissues deep in the sinonasal …See details»

Lyra Therapeutics Reports Fourth Quarter and Full Year 2022 …

Mar 29, 2023 · Lyra Therapeutics, Inc. is a clinical-stage biotechnology company developing therapies for the localized treatment of patients with chronic rhinosinusitis (CRS).See details»

Lyra Therapeutics Reports Topline Results from Phase 3 …

WATERTOWN, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), today announced topline results from the Company’s Phase …See details»

Lyra Therapeutics Announces First Patient Treated in Phase 2 …

Apr 25, 2022 · Lyra Therapeutics, Inc. is a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, local delivery of medications to …See details»

Pipeline - Lyra Therapeutics

Lyra Therapeutics’ product candidates are designed to provide medicine directly to sinonasal tissues that are not accessible with conventional therapeutic approaches.See details»

Job Opportunities - Lyra Therapeutics

Lyra Therapeutics is an equal-opportunity employer, offering competitive cash and stock-based compensation, excellent employee benefits and tremendous opportunity for personal and …See details»

linkstock.net © 2022. All rights reserved